within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03G_GonadotropinsAndOtherOvulationStimulants.G03GA02_HumanMenopausalGonadotrophin;
model HumanMenopausalGonadotrophin 
   extends Pharmacolibrary.Drugs.ATC.G.G03GA02;

  annotation(Documentation(
    info ="<html><body><p>Human menopausal gonadotrophin (hMG) is a combination of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) extracted from the urine of postmenopausal women. It is primarily used for the treatment of infertility in women, particularly for inducing ovulation and controlled ovarian hyperstimulation in assisted reproductive technology. hMG is approved for clinical use and remains widely used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated for healthy adult women undergoing ovarian stimulation. No comprehensive pharmacokinetic clinical study with full compartmental modeling has been published; values are based on non-compartmental estimations and summary data available in drug monographs.</p><h4>References</h4><ol><li><p>Dobbs, KE, et al., &amp; Shapiro, SS (1994). Differences in serum follicle-stimulating hormone uptake after intramuscular and subcutaneous human menopausal gonadotropin injection. <i>Fertility and sterility</i> 62(5) 978–983. DOI:<a href=&quot;https://doi.org/10.1016/s0015-0282(16)57061-7&quot;>10.1016/s0015-0282(16)57061-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7926145/&quot;>https://pubmed.ncbi.nlm.nih.gov/7926145</a></p></li><li><p> (2003). Urofollitropin - Ferring: FERRING hFSH, hFSH - Ferring, human follicle-stimulating hormone - Ferring, Bravelle. <i>BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</i> 17(4) 288–289. DOI:<a href=&quot;https://doi.org/10.2165/00063030-200317040-00008&quot;>10.2165/00063030-200317040-00008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12899646/&quot;>https://pubmed.ncbi.nlm.nih.gov/12899646</a></p></li><li><p>Di Stefano, AF, et al., &amp; Cometti, B (2016). Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin. <i>Clinical drug investigation</i> 36(12) 1031–1044. DOI:<a href=&quot;https://doi.org/10.1007/s40261-016-0451-6&quot;>10.1007/s40261-016-0451-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27638053/&quot;>https://pubmed.ncbi.nlm.nih.gov/27638053</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end HumanMenopausalGonadotrophin;
